Device Trial Radar · NCT06263946
Essilor® Stellest® Lenses Multicentre European Study (SLOMES)
Last checked: Nov 20, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Mar 22, 2024
Primary completion
May 4, 2027
Study completion May 4, 2027
Sponsor
- Lead sponsor
- Essilor InternationalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 16, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 6 years, up to 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this post-market clinical follow up Study is to demonstrate the efficacy, safety, acceptability, and quality of life implications of Essilor® Stellest® spectacle lenses in slowing myopia progression in European children and adolescents. Participants will receive Essilor® Stellest® at inclusion visit and will be asked for a full time wear (\>12 hours daily) for 24 months. The primary endpoints are the change in axial length and cycloplegic autorefraction from baseline to 24 months compared to expected change based on axial length and refraction centile positions at baseline.
Conditions
- Myopia
Interventions
Essilor® Stellest® spectacle lensesDevice
patients will be asked to wear Essilor® Stellest® spectacle lenses more than 12 hours per day for 24 months.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in cycloplegic axial lengthTime frame: from baseline to 24 months
- Change in cycloplegic autorefractionTime frame: from baseline to 24 months
Locations
3 sites in 3 countries. Site status is shown where the registry gives one.
Hôpital Fondation Adolphe de Rothschild - Ophthalmology Department
Paris, France
Centre for Eye Research Ireland (CERI) - TU DUBLIN
Dublin, Ireland
Erasmus Medical Center
Rotterdam, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.